Cullinan Therapeutics, Inc. (CGEM)
13.65
-0.23
(-1.66%)
USD |
NASDAQ |
Feb 20, 16:00
13.50
-0.15
(-1.10%)
After-Hours: 20:00
Cullinan Therapeutics Shareholders Equity (Quarterly) : 451.37M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 789.18M |
| Amgen, Inc. | 8.658B |
| Regeneron Pharmaceuticals, Inc. | 31.26B |
| MacroGenics, Inc. | 67.00M |
| Xencor, Inc. | 625.32M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 484.13M |
| Total Liabilities (Quarterly) | 32.76M |
| Debt to Equity Ratio | 0.0026 |
| Current Ratio | 10.45 |
| Net Debt Paydown Yield | 0.09% |